Sabby Management’s Arcadia Biosciences RKDA Stock Holding History

Sabby Management’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7	Closed	-$29K	–	135
2022 Q2	$29K	Sell	7 -7	-50%	-$322	0.02%	113
2022 Q1	$77K	Buy	14 +1	+8%	+$48	0.01%	123
2021 Q4	$56K	Sell	13 -70	-84%	-$4.56K	0.01%	167
2021 Q3	$684K	Sell	83 -126	-60%	-$11.8K	0.09%	106
2021 Q2	$2.48M	Buy	209 +113	+118%	+$12.3K	0.35%	40
2021 Q1	$1.05M	Buy	96 +90	+1,500%	+$11K	0.2%	78
2020 Q4	$61K	Buy	+6	New	+$732	0.01%	98

Other funds holding RKDA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Sabby Management's RKDA Position: Q1 2026 in Review

Sabby Management opened a new position in Arcadia Biosciences (RKDA) in Q1 2026: 114,554 shares worth $158K. The stake represents 0.35% of the portfolio and ranks #17 among its holdings. This is a return to the name: Sabby Management previously reported a position in RKDA as recently as Q1 2024.

Sabby Management first reported a position in RKDA in Q1 2018 and has held it in 17 quarters since. The position peaked at $3.61M in Q1 2018. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

Sabby Management held 114,554 shares of Arcadia Biosciences worth $158K as of Q1 2026.
Arcadia Biosciences was a new Sabby Management position in Q1 2026.
Arcadia Biosciences made up 0.35% of Sabby Management's portfolio in Q1 2026, its #17 holding.
Sabby Management first reported a position in Arcadia Biosciences in Q1 2018 and has held it in 17 quarters since.
Sabby Management's Arcadia Biosciences position peaked at $3.61M in Q1 2018.
16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Sabby Management's 13F filing for Q1 2026, filed 15 May 2026.